View More Recent Stories

Aug 5, 2015 07:35AM ARIAD Reports Second Quarter 2015 Financial Results and Progress on Strategic Objectives
Jul 29, 2015 07:35AM ARIAD to Receive up to $200 Million Through Iclusig Non-Dilutive Synthetic-Royalty Financing with PDL BioPharma
Jul 29, 2015 07:35AM PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals
Jul 22, 2015 07:35AM ARIAD to Webcast Conference Call on Second Quarter 2015 Financial Results
Jun 12, 2015 11:15AM ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial
Jun 10, 2015 07:35AM ARIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada
Jun 8, 2015 07:35AM ARIAD to Present at the Goldman Sachs Annual Global Healthcare Conference
Jun 1, 2015 09:00AM ARIAD Presents Updated Clinical Data on brigatinib in Patients with ALK+ Non-Small Cell Lung Cancer at the 2015 ASCO Meeting
May 31, 2015 09:00AM ARIAD Announces Long-Term Safety and Efficacy Data Of Ponatinib in Chronic-Phase Chronic Myeloid Leukemia from Phase 1 Clinical Trial
May 22, 2015 07:35AM ARIAD Announces Data Presentations at the European Hematology Association (EHA) Congress
May 21, 2015 07:35AM ARIAD to Present at the Jefferies 2015 Global Healthcare Conference
May 14, 2015 07:35AM ARIAD Announces Data Presentations at the 2015 ASCO Annual Meeting
May 7, 2015 07:35AM ARIAD Reports First Quarter 2015 Financial Results and Progress on Strategic Objectives
May 6, 2015 07:35AM ARIAD Announces Commercial Distribution Agreement for Iclusig (ponatinib) in Turkey
Apr 29, 2015 09:26AM Pre-Open Stock Movers 04/29: (XPO) (GPRO) (HOT) Higher; (IG) (SSYS) (LL) (WYNN) Lower (more...)
Apr 29, 2015 07:00AM ARIAD Enters into Settlement Agreement with Sarissa Capital Management
Apr 29, 2015 06:49AM ARIAD Founder, Harvey J. Berger, M.D., to Retire as Chairman and Chief Executive Officer
Apr 23, 2015 07:35AM ARIAD to Webcast Conference Call on First Quarter 2015 Financial Results
Apr 22, 2015 07:35AM ARIAD Announces Issuance of Key U.S. Patent on Brigatinib
Apr 21, 2015 07:35AM ARIAD Announces Results of Preclinical Studies on Brigatinib at the American Association for Cancer Research Annual Meeting
Apr 17, 2015 07:35AM ARIAD Presents Updated Clinical Data on Brigatinib in Patients with ALK+ Non-Small Cell Lung Cancer
Apr 6, 2015 07:35AM ARIAD Announces Approval of Iclusig (as Ponatinib Hydrochloride) in Canada
Mar 25, 2015 09:28AM ARIAD Announces Dismissal of Shareholder Class Action Lawsuit in Federal District Court
Mar 24, 2015 07:35AM ARIAD and Medison Pharma Announce Approval of Iclusig (Ponatinib) in Israel
Mar 19, 2015 07:35AM ARIAD Announces Presentations of Preclinical Data at American Association for Cancer Research Annual Meeting
Mar 10, 2015 04:20PM ARIAD Announces Dismissal of Shareholder Derivative Lawsuit in Federal District Court
Oct 2, 2014 05:27PM Market Wrap: GoPro Slumps on Share Shift; JPMorgan Breach Affects Millions; Buffett's 'Revved-Up' Purchase
Oct 2, 2014 09:28AM Pre-Open Stock Movers 10/02: (ESPR) (RLD) (TSLA) Higher; (CREE) (WILN) (GPRO) Lower (more...)
Jan 6, 2014 09:37AM Pre-Open Stock Movers 1/6: (SCTY) (RDWR) (SIRI) Higher; (SCSS) (HGG) (TWTR) Lower (more...)
Dec 24, 2013 09:22AM Pre-Open Stock Movers 12/24: (ATOS) (TLSA) (TWTR) Higher; (CAMP) (GLUU) (DDD) Lower (more...)
Oct 31, 2013 05:28PM Market Wrap: Acitivity Picks Up in Chicago; A Bigger Clothing Deal?; Twitter IPO Coming Soon
Dec 6, 2010 09:02AM Ariad (ARIA) May Have Been Best at ASH Meeting
View More Recent Stories